• Profound Medical Corp. schedules annual and special shareholder meeting in Mississauga, Ontario on May 13, 2026.
• Shareholders will vote on election of eight directors.
• Ballot includes approval of unallocated restricted share units and deferred share units under long-term incentive plan, extending grant authority through May 13, 2029.
• Auditor appointment also up for vote, with PricewaterhouseCoopers LLP proposed for the ensuing year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profound Medical Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-062509), on May 15, 2026, and is solely responsible for the information contained therein.